421 related articles for article (PubMed ID: 30356438)
1. Community-Acquired Urinary Tract Infection by
Lee DS; Lee SJ; Choe HS
Biomed Res Int; 2018; 2018():7656752. PubMed ID: 30356438
[TBL] [Abstract][Full Text] [Related]
2. Microbial risk factors for treatment failure of pivmecillinam in community-acquired urinary tract infections caused by ESBL-producing Escherichia coli.
Syre H; Hetland MAK; Bernhoff E; Bollestad M; Grude N; Simonsen GS; Löhr IH
APMIS; 2020 Mar; 128(3):232-241. PubMed ID: 31755584
[TBL] [Abstract][Full Text] [Related]
3. Multiresistant Escherichia coli isolated from women with community-acquired urinary tract infections in the Gaza Strip.
Astal Z; Sharif FA; Abdallah SA; Fahd MI
J Chemother; 2002 Dec; 14(6):637-8. PubMed ID: 12583559
[No Abstract] [Full Text] [Related]
4. Antibiotic resistance in isolates recovered from women with community-acquired urinary tract infections presenting to a tertiary care emergency department.
Filiatrault L; McKay RM; Patrick DM; Roscoe DL; Quan G; Brubacher J; Collins KM
CJEM; 2012 Sep; 14(5):295-305. PubMed ID: 22967697
[TBL] [Abstract][Full Text] [Related]
5. Resistance to fluoroquinolones and treatment failure/short-term relapse of community-acquired urinary tract infections caused by Escherichia coli.
Gagliotti C; Buttazzi R; Sforza S; Moro ML;
J Infect; 2008 Sep; 57(3):179-84. PubMed ID: 18707763
[TBL] [Abstract][Full Text] [Related]
6. [Susceptibility to antibiotics of Escherichia coli isolated from community-acquired urinary tract infections].
Fabre R; Mérens A; Lefebvre F; Epifanoff G; Cerutti F; Pupin H; Tardif D; Cavallo JD; Ternois I
Med Mal Infect; 2010 Oct; 40(10):555-9. PubMed ID: 20417046
[TBL] [Abstract][Full Text] [Related]
7. An 11-year analysis of the prevalent uropathogens and the changing pattern of Escherichia coli antibiotic resistance in 38,530 community urinary tract infections, Dublin 1999-2009.
Cullen IM; Manecksha RP; McCullagh E; Ahmad S; O'Kelly F; Flynn R; McDermott TE; Murphy P; Grainger R; Fennell JP; Thornhill JA
Ir J Med Sci; 2013 Mar; 182(1):81-9. PubMed ID: 22669684
[TBL] [Abstract][Full Text] [Related]
8. Fluoroquinolone-Resistant Sequence Type 131 Subgroups O25b and O16 Among Extraintestinal Escherichia coli Isolates from Community-Acquired Urinary Tract Infections.
Hefzy EM; Hassuna NA
Microb Drug Resist; 2017 Mar; 23(2):224-229. PubMed ID: 27214282
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for ciprofloxacin resistance among Escherichia coli strains isolated from community-acquired urinary tract infections in Turkey.
Arslan H; Azap OK; Ergönül O; Timurkaynak F;
J Antimicrob Chemother; 2005 Nov; 56(5):914-8. PubMed ID: 16174685
[TBL] [Abstract][Full Text] [Related]
10. Joint Modeling of Resistance to Six Antimicrobials in Urinary Escherichia coli Isolates in Quebec, Canada.
Soucy JR; Schmidt AM; Frenette C; Dolcé P; Boudreault AA; Buckeridge DL; Quach C
Antimicrob Agents Chemother; 2019 Jul; 63(7):. PubMed ID: 31010864
[TBL] [Abstract][Full Text] [Related]
11. [Current state of antibiotic resistance of pathogens causing community-acquired urinary tract infections in Russia, Belarus and Kazakhstan: results of the international multicenter study Darmis-2018].
Palagin IS; Sukhorukova MV; Dekhnich AV; Edelstein MV; Perepanova TS; Kozlov RS
Urologiia; 2020 Mar; (1):19-31. PubMed ID: 32190999
[TBL] [Abstract][Full Text] [Related]
12. Prior antibiotics and risk of antibiotic-resistant community-acquired urinary tract infection: a case-control study.
Hillier S; Roberts Z; Dunstan F; Butler C; Howard A; Palmer S
J Antimicrob Chemother; 2007 Jul; 60(1):92-9. PubMed ID: 17540675
[TBL] [Abstract][Full Text] [Related]
13. Risk factors for community-onset urinary tract infections caused by extended-spectrum β-lactamase-producing Escherichia coli.
Tüzün T; Sayın Kutlu S; Kutlu M; Kaleli İ
Turk J Med Sci; 2019 Aug; 49(4):1206-1211. PubMed ID: 31385490
[TBL] [Abstract][Full Text] [Related]
14. Association between urinary community-acquired fluoroquinolone-resistant Escherichia coli and neighbourhood antibiotic consumption: a population-based case-control study.
Low M; Neuberger A; Hooton TM; Green MS; Raz R; Balicer RD; Almog R
Lancet Infect Dis; 2019 Apr; 19(4):419-428. PubMed ID: 30846277
[TBL] [Abstract][Full Text] [Related]
15. Increased community-acquired upper urinary tract infections caused by extended-spectrum beta-lactamase-producing Escherichia coli in children and the efficacy of flomoxef and cefmetazole.
Horie A; Nariai A; Katou F; Abe Y; Saito Y; Koike D; Hirade T; Ito T; Wakuri M; Fukuma A
Clin Exp Nephrol; 2019 Nov; 23(11):1306-1314. PubMed ID: 31428892
[TBL] [Abstract][Full Text] [Related]
16. Antibiotic resistance patterns of pediatric community-acquired urinary tract infections in a tertiary care center in Jeddah, Saudi Arabia.
Alsubaie MA; Alsuheili AZ; Aljehani MN; Alothman AA; Alzahrani AS; Mohammedfadel HA; Alshehry MA; Alnajjar AA
J Infect Dev Ctries; 2023 Oct; 17(10):1430-1435. PubMed ID: 37956373
[TBL] [Abstract][Full Text] [Related]
17. Potential role of fosfomycin in the treatment of community-acquired lower urinary tract infections caused by extended-spectrum β-lactamase-producing Escherichia coli.
Wilson DT; May DB
Am J Ther; 2013; 20(6):685-90. PubMed ID: 21768870
[TBL] [Abstract][Full Text] [Related]
18. Extended-spectrum β-lactamase-producing Gram-negative pathogens in community-acquired urinary tract infections: an increasing challenge for antimicrobial therapy.
Meier S; Weber R; Zbinden R; Ruef C; Hasse B
Infection; 2011 Aug; 39(4):333-40. PubMed ID: 21706226
[TBL] [Abstract][Full Text] [Related]
19. Pulsed-field gel electrophoresis typing of Escherichia coli strains from samples collected before and after pivmecillinam or placebo treatment of uncomplicated community-acquired urinary tract infection in women.
Ejrnaes K; Sandvang D; Lundgren B; Ferry S; Holm S; Monsen T; Lundholm R; Frimodt-Moller N
J Clin Microbiol; 2006 May; 44(5):1776-81. PubMed ID: 16672406
[TBL] [Abstract][Full Text] [Related]
20. Clinical and microbiological profile of urinary tract infection at a tertiary-care center in Lebanon.
Fadel R; Dakdouki GK; Kanafani ZA; Araj GF; Kanj SS
Infect Control Hosp Epidemiol; 2004 Jan; 25(1):82-5. PubMed ID: 14756226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
